港股异动 | 阿里健康(00241)跌超4% 高盛预计AI及药品类别投资增加影响公司盈利

智通财经04-09

智通财经APP获悉，阿里健康(00241)跌超4%，截至发稿，跌4.08%，报4.7港元，成交额4.44亿港元。消息面上，高盛发布研报称，将阿里健康目标价由5.2港元降至4.8港元，评级为“中性”，以反映AI及药品类别投资增加影响盈利能力。报告指，阿里健康股价年初至今仅跌3%，跑赢恒生科技指数的11%跌幅，主要受惠于增长预期及AI医疗潜力。然而，该行预计公司下半年利润将小幅倒退，扭转上半年的利润...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2626905709?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-09 14:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626905709","market":"us","top_or_hot":-1,"title":"港股异动 | 阿里健康(00241)跌超4% 高盛预计AI及药品类别投资增加影响公司盈利","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，阿里健康(00241)跌超4%，截至发稿，跌4.08%，报4.7港元，成交额4.44亿港元。消息面上，高盛发布研报称，将阿里健康目标价由5.2港元降至4.8港元，评级为“中性”，以反映AI及药品类别投资增加影响盈利能力。报告指，阿里健康股价年初至今仅跌3%，跑赢恒生科技指数的11%跌幅，主要受惠于增长预期及AI医疗潜力。然而，该行预计公司下半年利润将小幅倒退，扭转上半年的利润...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1426442.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 阿里健康(00241)跌超4% 高盛预计AI及药品类别投资增加影响公司盈利</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 阿里健康(00241)跌超4% 高盛预计AI及药品类别投资增加影响公司盈利\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-09 14:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1426442.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，阿里健康(00241)跌超4%，截至发稿，跌4.08%，报4.7港元，成交额4.44亿港元。消息面上，高盛发布研报称，将阿里健康目标价由5.2港元降至4.8港元，评级为“中性”，以反映AI及药品类别投资增加影响盈利能力。报告指，阿里健康股价年初至今仅跌3%，跑赢恒生科技指数的11%跌幅，主要受惠于增长预期及AI医疗潜力。然而，该行预计公司下半年利润将小幅倒退，扭转上半年的利润...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1426442.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237443382.USD","symbol_name":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1426442.html","article_id":"2626905709","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2626905709","pubTimestamp":1775715452,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，阿里健康(00241)跌超4%，截至发稿，跌4.08%，报4.7港元，成交额4.44亿港元。消息面上，高盛发布研报称，将阿里健康目标价由5.2港元降至4.8港元，评级为“中性”，以反映AI及药品类别投资增加影响盈利能力。报告指，阿里健康股价年初至今仅跌3%，跑赢恒生科技指数的11%跌幅，主要受惠于增长预期及AI医疗潜力。然而，该行预计公司下半年利润将小幅倒退，扭转上半年的利润扩张趋势，主要由于AI计划投入增加，以及为应对竞争而加大原研药折扣力度。AI投资预期将延续至2027财年。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","AGIX":"通用人工智能 ETF-AGIX","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","BK4516":"特朗普概念","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","BK1502":"双十一","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","BK4504":"桥水持仓","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","BK1501":"阿里概念股","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","BK4588":"碎股","ARTY":"ISHARES FUTURE AI & TECH ETF","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK1142":"互联网与直销零售","BK4552":"Archegos爆仓风波概念","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","AIPO":"Defiance AI and Power Infrastructure ETF","00241":"阿里健康","BK1610":"ETF&股票定投概念","LU0106831901.USD":"贝莱德世界金融基金A2","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","BK1615":"港股-互联网","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","BK1584":"蚂蚁金服概念","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK1571":"互联网医疗","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK1591":"就地过年概念","BK4127":"投资银行业与经纪业","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","VXUS":"国际股票ETF-Vanguard","GSX":"Tradr 2X Long GS Daily ETF","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC"},"translate_title":"Changes in Hong Kong stocks | Alibaba Health (00241) fell more than 4% Goldman Sachs expects increased investment in AI and pharmaceutical categories to affect the company's earnings","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1.5,"AIPO":1.5,"ARTY":1.5,"AGIX":1.5,"GSX":0.6,"VXUS":1.5,"CHAT":1.5},"content_text":"智通财经APP获悉，阿里健康(00241)跌超4%，截至发稿，跌4.08%，报4.7港元，成交额4.44亿港元。消息面上，高盛发布研报称，将阿里健康目标价由5.2港元降至4.8港元，评级为“中性”，以反映AI及药品类别投资增加影响盈利能力。报告指，阿里健康股价年初至今仅跌3%，跑赢恒生科技指数的11%跌幅，主要受惠于增长预期及AI医疗潜力。然而，该行预计公司下半年利润将小幅倒退，扭转上半年的利润扩张趋势，主要由于AI计划投入增加，以及为应对竞争而加大原研药折扣力度。AI投资预期将延续至2027财年。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626905709","isCrawlerRequest":true}